Your browser doesn't support javascript.
loading
Plasma-first: accelerating lung cancer diagnosis and molecular profiling through liquid biopsy.
Garcia-Pardo, Miguel; Czarnecka, Kasia; Law, Jennifer H; Salvarrey, Alexandra; Fernandes, Roxanne; Fan, Jason; Corke, Lucy; Waddell, Thomas K; Yasufuku, Kazuhiro; Donahoe, Laura L; Pierre, Andrew; Le, Lisa W; Ghumman, Noor; Liu, Geoffrey; Shepherd, Frances A; Bradbury, Penelope; Sacher, Adrian; Stockley, Tracy; Pal, Prodipto; Rogalla, Patrik; Tsao, Ming Sound; Leighl, Natasha B.
Affiliation
  • Garcia-Pardo M; Division of Medical Oncology and Hematology, Princess Margaret Cancer Centre, University Health Network, Toronto, ON, Canada.
  • Czarnecka K; Division of Respirology, Toronto General Hospital, University Health Network, Toronto, ON, Canada.
  • Law JH; Division of Medical Oncology and Hematology, Princess Margaret Cancer Centre, University Health Network, Toronto, ON, Canada.
  • Salvarrey A; Division of Medical Oncology and Hematology, Princess Margaret Cancer Centre, University Health Network, Toronto, ON, CanadaDivision of Thoracic Surgery, Toronto General Hospital, University Health Network, Toronto, ON, Canada.
  • Fernandes R; Division of Medical Oncology and Hematology, Princess Margaret Cancer Centre, University Health Network, Toronto, ON, Canada.
  • Fan J; Division of Medical Oncology and Hematology, Princess Margaret Cancer Centre, University Health Network, Toronto, ON, Canada.
  • Corke L; Division of Medical Oncology and Hematology, Princess Margaret Cancer Centre, University Health Network, Toronto, ON, Canada.
  • Waddell TK; Division of Thoracic Surgery, Toronto General Hospital, University Health Network, Toronto, ON, Canada.
  • Yasufuku K; Division of Thoracic Surgery, Toronto General Hospital, University Health Network, Toronto, ON, Canada.
  • Donahoe LL; Division of Thoracic Surgery, Toronto General Hospital, University Health Network, Toronto, ON, Canada.
  • Pierre A; Division of Thoracic Surgery, Toronto General Hospital, University Health Network, Toronto, ON, Canada.
  • Le LW; Department of Biostatistics, Princess Margaret Cancer Centre, University Health Network, Toronto, ON, Canada.
  • Ghumman N; Division of Medical Oncology and Hematology, Princess Margaret Cancer Centre, University Health Network, Toronto, ON, Canada.
  • Liu G; Division of Medical Oncology and Hematology, Princess Margaret Cancer Centre, University Health Network, Toronto, ON, Canada.
  • Shepherd FA; Division of Medical Oncology and Hematology, Princess Margaret Cancer Centre, University Health Network, Toronto, ON, Canada.
  • Bradbury P; Division of Medical Oncology and Hematology, Princess Margaret Cancer Centre, University Health Network, Toronto, ON, Canada.
  • Sacher A; Division of Medical Oncology and Hematology, Princess Margaret Cancer Centre, University Health Network, Toronto, ON, Canada.
  • Stockley T; Department of Laboratory Medicine and Pathobiology, Toronto General Hospital, University Health Network, Toronto, ON, Canada.
  • Pal P; Department of Laboratory Medicine and Pathobiology, Toronto General Hospital, University Health Network, Toronto, ON, Canada.
  • Rogalla P; Joint Department of Medical Imaging, Toronto General Hospital, University Health Network, Toronto, ON, Canada.
  • Tsao MS; Department of Laboratory Medicine and Pathobiology, Toronto General Hospital, University Health Network, Toronto, ON, Canada.
  • Leighl NB; Division of Medical Oncology and Hematology, Princess Margaret Cancer Centre, University Health Network, 7-913 700 University Avenue, Toronto, ON M5G 1Z5, Canada.
Ther Adv Med Oncol ; 14: 17588359221126151, 2022.
Article de En | MEDLINE | ID: mdl-36158638

Texte intégral: 1 Collection: 01-internacional Base de données: MEDLINE Type d'étude: Diagnostic_studies / Prognostic_studies Langue: En Journal: Ther Adv Med Oncol Année: 2022 Type de document: Article Pays d'affiliation: Canada Pays de publication: Royaume-Uni

Texte intégral: 1 Collection: 01-internacional Base de données: MEDLINE Type d'étude: Diagnostic_studies / Prognostic_studies Langue: En Journal: Ther Adv Med Oncol Année: 2022 Type de document: Article Pays d'affiliation: Canada Pays de publication: Royaume-Uni